• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details


A New Hope in the Prevention of Shingles

Program Type

OnDemand

Credits

1 Contact Hour(s)

Release Date

Wednesday, November 21, 2018

Offline Date:

Saturday, November 21, 2020

ACPE Expiration Date

Friday, May 21, 2021

Target Audience

Nurse, Pharmacist, Pharmacy Technician

Cost

$4.00

  • Overview

    Shingles is cause by a reactivation of latent varicella-zoster (VZV) virus. Risk of reactivation is a reality in more than 90% of adults who have been infected by VZV. Shingles can cause considerable pain and most notably can cause postherpetic neuralgia as a complication. Zostavax was recommended to prevent shingles in individuals over the age of 50 but was 50% effective in preventing VZV reactivation. Shingrix was approved by the FDA in October 2017. Shingrix has been shown to have an efficacy of >90% thanks to the use of adjuvant technology. It is recommended for use in adults over the age of 50. It will be important for pharmacists, pharmacy technicians and nurses to be aware of the new vaccine product to prevent shingles in a greater number of older adults.

    Rating


    Handouts

    Slide Document:   18072H06_2pp.pdf
    Slide Document:   18072H06_4pp.pdf

    Financial Support By

    PharmCon, Inc.
  • Nurse

    Describe the epidemiology of shingles
    List 3 clinical features of shingles
    Compare and contrast the efficacy of the available shingles vaccines


    Pharmacist

    Describe the epidemiology of shingles
    List 3 clinical features of shingles
    Compare and contrast the efficacy of the available shingles vaccines


    Pharmacy Technician

    Describe the epidemiology of shingles
    List 3 clinical features of shingles
    Define the term adjuvant

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-18-071-H06-N

    Pharmacist 0798-0000-18-071-H06-P

    Pharmacy Technician 0798-0000-18-071-H06-T

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.